Niloofar Yavari

Niloofar Yavari is a Postdoctoral Researcher in the Department of Cellular and Molecular Medicine at the University of Copenhagen, working within the Transcription, RNA, and Gene Medicine Program under Professor Nielsen PE's research group. Her position focuses on advanced molecular therapeutic development with emphasis on peptide-based technologies.

Her research program centers on peptide nucleic acid (PNA) technology and its applications across multiple therapeutic domains:

• Development of novel antisense antibiotics targeting Gram-negative bacterial pathogens
• Therapeutic approaches for muscular dystrophy and cystic fibrosis
• Gene targeting mechanisms and antisense principles for disease intervention
• Overcoming cellular and in vivo delivery barriers for biopharmaceuticals
• Investigation of oxidative stress effects on cellular RNA

Analysis of her publication record reveals a strategic research trajectory focused on solving delivery challenges for nucleic acid therapeutics. Her work demonstrates increasing sophistication in understanding bacterial membrane interactions, with recent publications exploring LPS composition effects and SbmA-independent delivery mechanisms. The interdisciplinary nature of her research bridges molecular biology, pharmaceutical sciences, and clinical applications, particularly evident in her work on extracellular vesicles for diabetes therapy.

Dr. Yavari maintains active collaborations across multiple research groups, contributing to projects that span infectious disease, genetic disorders, and autoimmune conditions. Her work has generated significant academic interest, with multiple publications receiving attention on scholarly platforms and one study referenced in patent literature, indicating translational potential.